References
- Dickens C. Household Words 1852;95:385–9
- Burger HG, Hale GE, Robertson DM, Dennerstein L. A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project. Hum Reprod Update 2007;13:559–65
- Studd J, Nappi R. Reproductive depression. Gynecol Endocrinol 2012;28:42–5
- Studd J. A guide to the treatment of depression in women by estrogens. Climacteric 2011;14:637–42
- Studd J. Severe premenstrual syndrome and bipolar disorder: a frequent tragic confusion. Climacteric 2011;14:602
- Freeman MP, Smith KW, Freeman SA, et al. The impact of reproductive events on the course of bipolar disorder in women. J Clin Psychiatry 2002;63:284–7
- Sharma V, Burt V, Ritchie H. Assessment and treatment of bipolar II postpartum depression: a review. J Affect Disord 2010; 125:18–26
- Jones I, Craddock N. Familiarity of the puerperal trigger in bipolar disorder: results of a family study. Am J Psychiatry 2001;158:913–17
- Bloch M, Schmidt PJ, Danaceau M, Murphy J, Nieman L, Rubinow DR. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000;157: 924–30
- Graziottin A, Serafini A. Depression and the menopause: why antidepressants are not enough? Menopause Int 2009;15: 76–81
- Craig M. Should psychiatrists prescribe oestrogen therapy to their female patients? Br J Psychiatry 2013;202:9–13
- Watson NR, Studd JW, Savvas M, Garnett T, Baber RJ. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet 1989;2:730–2
- Magos AL, Brincat M, Studd JW. Treatment of the premenstrual syndrome by subcutaneous estradiol implants and cyclical oral norethisterone: placebo controlled study. Br Med J 1986;292: 1629–33
- Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996;347:930–3
- Soares CN, Almeida OP, Joffe H, Cohen LS. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2001;58:529–34
- Montgomery JC, Appleby L, Brincat M, et al. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1987;1(8528):297–9
- Davis SR, McCloud P, Strauss BJG, Burger H. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 1995;21:227–36
- Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: a prospective crossover study of sex steroid administration in the surgical menopause. Psychosom Med 1985;47:339–51
- Sands R, Studd J. Exogenous androgens in postmenopausal women. Am J Med 1995;98:76–9
- Panay N, Studd J. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Hum Reprod Update 1997;3:159–71
- Casson P, Hahn PM, Van Vugt DA, Reid RL. Lasting response to ovariectomy in severe intractable premenstrual syndrome. Am J Obstet Gynecol 1990;162:99–105
- Cronje WH, Vashisht A, Studd JW. Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Hum Reprod 2004;19:2152–5
- Panay N, Studd JW. The psychotherapeutic effects of estrogens. Gynecol Endocrinol 1998;12:353–65
- Studd J, Panay N. Are oestrogens useful for the treatment of depression in women? Best Pract Res Clin Obstet Gynaecol 2009;23:63–71
- de Villiers TJ, Gass ML, Haines CJ, et al. Global consensus statement on menopausal hormone therapy. Climacteric 2013;16: 203–4
- Schierbeck LL, Rejnmark L, Tofteng CL, et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ 2012;345:2012:e6409
- Renoux C, Dell’aniello S, Garbe E, Suissa S. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ 2010;340:c2519